Randomized trials
Interdisciplinary frailty RCT
Open access · cc by · source: Europe PMC
A 12-month multifactorial interdisciplinary program reduced frailty prevalence and improved mobility versus usual care in frail older adults in Sydney.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Multiple studies in this library examine randomized trials with empirical patient or population outcomes rather than opinion alone.
Evidence for the claim as stated.
At 12 months, frailty prevalence was 14.7 percentage points lower with intervention (NNT ≈ 6.8) and SPPB mobility improved relative to controls; effects were clearer at 12 months than at 3 months.
Evidence for the claim as stated.
Effect sizes and settings differ across randomized trials studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Effect sizes and settings differ across randomized trials studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
Study at a glance
- Design
- RCT — Single-center RCT; year-long multifactorial interdisciplinary intervention vs usual care
- N
- N=241 · Enrolled of 322 eligible (75%)
- Population
- Frail older adults in an Australian health system (mean age ~83)
- Outcome
- Frailty prevalence and SPPB mobility at 3 and 12 months
Structured fields used in claim comparison tables when every cited study has a complete layer.
Inspect source passages
Interdisciplinary frailty RCT
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
241 of 322 eligible people (75%) agreed to participate.
Of the eligible people approached, 75% (241 out of 322) agreed to participate in the trial.
Mean age was 83.3 years and 68% were women.
Women constituted 68% of participants, and the mean age was 83.3 years.
Key findings
At 12 months, frailty prevalence was 14.7 percentage points lower with intervention (NNT ≈ 6.8) and SPPB mobility improved relative to controls; effects were clearer at 12 months than at 3 months.
Methodology
A single-center RCT randomized frail older adults to a year-long multifactorial interdisciplinary intervention (physiotherapy, nutrition, medical review as needed) or usual care, assessing frailty and SPPB at 3 and 12 months.
Limitations
Results are from one Australian health system and do not isolate which component drove benefit or guarantee mortality reduction.
Related papers in this topic
Same topic cluster — not a recommendation engine.